Reduced NF-κB activity was also associated with decreased PICs, suggesting that attenuation of NF-κB activity might be attributable to reduced PVN inflammation, which in turn leads to disruption of detrimental positive feed-back cycle involved in cardiac hypertrophy and the progression of hypertension. The gene discussed is NFKB1; the disease is cardiac hypertrophy.